FDA approves new kind of treatment for hairy cell leukemia - FDA Press Releases

FDA approves Lumoxiti (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia

from Food and Drug Administration--Press Releases https://ift.tt/2Ok6Qyu
via IFTTT